ArticleEuropean journal of nuclear medicine and molecular imaging2024

Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.

Manuel Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.